Back

The utility of CRISPR gene editing in cardiology

30 August 2026 (15:30 - 15:40)
Organised by: Logo
Congress Presentation Part of: Targeting the source: in vivo CRISPR-based gene editing for transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Ronald Witteles

Stanford University, Stanford (United States of America)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction
Doctor A. Masri (Portland, US)
Presentation thumbnail
Complexities of patient care in ATTR amyloidosis
Assistant Professor J. Vaishnav (Baltimore, US)
Presentation thumbnail
Exploring CRISPR-based gene editing in ATTR-CM
Doctor A. Masri (Portland, US)
Presentation thumbnail
Targeting the source: in vivo CRISPR-based gene editing for ATTR-CM - Q&A from the audience

Access the full session

Session thumbnail
Targeting the source: in vivo CRISPR-based gene editing for transthyretin amyloid cardiomyopathy (ATTR-CM)
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 15:30 CET
You may be interested in
thumbnail
Congress Session
Gene editing and gene therapies to cure cardiovascular diseases
31 August 2024
thumbnail
ESC TV Today
Episode 2: The why and how of MRAs in heart failure - Managing electrical storm
10 October 2024
thumbnail
Congress Session
Cardiogenetics in everyday practice
23 June 2023
thumbnail
Congress Session
What’s on the horizon in heart failure: precision medicine and tailored treatment
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources